Google Alert - "Myeloproliferative neoplasms" OR "polycythemia vera" OR myelofibrosis OR "essential thrombocythemia" · Scour

Whole genome sequencing unveils blood cancer trajectory

Decades-Long Study Uncovers the Evolution of Blood Cancers and Drivers of Disease Progression

Genomic evolution and natural history of myeloproliferative neoplasms on therapy

Retrospective Data Highlight Challenges, Potential Therapeutic Strategies With Allo-HSCT ...

G-BA Reassesses Omjjara, Finds No Added Benefit for Myelofibrosis Treatment

RICHARD SILVER Obituary (2026) - New York, NY - New York Times

Five Under 5: Top Oncology Videos for the Week of 4/12

The Myeloproliferative Disorder Treatment Market Size

Key Players and Competitive Dynamics in the Essential Thrombocythemia (ET) Market

Syntara's Myelofibrosis Drug Candidate Shows 'Significant' Commercial Potential, Euroz ...

Thrombocytosis: Rapid Evidence Review

Alethio unveils ATX-011 for essential thrombocythemia

Outcomes of allogeneic transplantation in blast-phase myeloproliferative neoplasms

Alethio Therapeutics unveils ATX-011, a breakthrough for treating essential thrombocythemia

Alethio Therapeutics Unveils ATX‑011, a Breakthrough, Mutation‑Agnostic Antibody for ...

Alethio Therapeutics Unveils ATX‑011, a Breakthrough, Mutation‑Agnostic Antibody for ...

Targeting CALR Mutations in Myeloproliferative Neoplasms

Dr Gerds on Targeting CALR Mutations in Myeloproliferative Neoplasms

Polycythemia Vera Market: Rapid Increment Driven by Innovation by 2034

CALR Mutation–Directed Agents and Targeted Therapies Represent Key Research Avenue ...

Log in to enable infinite scrolling